Literature DB >> 12856722

Establishment of an in vitro assay to measure the invasion of ovarian carcinoma cells through mesothelial cell monolayers.

Rachael C Casey1, Kimberly A Koch, Theodore R Oegema, Keith M Skubitz, Stefan E Pambuccian, Suzanne M Grindle, Amy P N Skubitz.   

Abstract

Ovarian carcinoma is the leading cause of gynecological cancer deaths in the United States. Secondary tumor growths form by tumor cell invasion through the mesothelial lining of the peritoneal cavity and peritoneal organs. To study this interaction, we developed a dye-based in vitro model system in which mesothelial cells were grown as confluent monolayers, permeabilized, and then co-cultured with ovarian carcinoma cells for up to seven days. The mesothelial cells were then stained with trypan blue dye, which enabled the visualization of ovarian carcinoma cell invasion through the monolayers of mesothelial cells. Ovarian carcinoma cell invasion was inhibited for up to 7 days by the addition of GRGDSP peptides, a blocking monoclonal antibody against the beta1 integrin subunit, or blocking monoclonal antibodies against matrix metalloproteinases 2 and 9. Cell invasion was also inhibited by hyaluronan and GM6001, a chemical inhibitor of matrix metalloproteinases. Differential gene expression of matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases, and disintegrins were observed in primary ovarian carcinoma tumors and secondary metastases, compared to normal ovaries. Taken together, these results suggest that complex interactions between integrins, disintegrins, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases may mediate ovarian carcinoma cell invasion, and that the dye-based assay described herein is a suitable model system for its study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12856722     DOI: 10.1023/a:1024009131191

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  38 in total

Review 1.  ADAMs and cell fusion.

Authors:  A P Huovila; E A Almeida; J M White
Journal:  Curr Opin Cell Biol       Date:  1996-10       Impact factor: 8.382

2.  Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells.

Authors:  D A Fishman; Y Liu; S M Ellerbroek; M S Stack
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

3.  Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites.

Authors:  R M Peterson; Q Yu; I Stamenkovic; B P Toole
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

4.  Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids.

Authors:  R C Casey; K M Burleson; K M Skubitz; S E Pambuccian; T R Oegema; L E Ruff; A P Skubitz
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

5.  Cancer statistics, 2002.

Authors:  Ahmedin Jemal; Andrea Thomas; Taylor Murray; Michael Thun
Journal:  CA Cancer J Clin       Date:  2002 Jan-Feb       Impact factor: 508.702

6.  Variants of the cell recognition site of fibronectin that retain attachment-promoting activity.

Authors:  M D Pierschbacher; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

7.  Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.

Authors:  S A Cannistra; G S Kansas; J Niloff; B DeFranzo; Y Kim; C Ottensmeier
Journal:  Cancer Res       Date:  1993-08-15       Impact factor: 12.701

8.  A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts.

Authors:  B Davies; P D Brown; N East; M J Crimmin; F R Balkwill
Journal:  Cancer Res       Date:  1993-05-01       Impact factor: 12.701

9.  High level of MT-MMP expression is associated with invasiveness of cervical cancer cells.

Authors:  C Gilles; M Polette; J Piette; C Munaut; E W Thompson; P Birembaut; J M Foidart
Journal:  Int J Cancer       Date:  1996-01-17       Impact factor: 7.396

10.  Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function.

Authors:  Q Yu; B P Toole; I Stamenkovic
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

View more
  16 in total

Review 1.  Epithelial ovarian cancer experimental models.

Authors:  E Lengyel; J E Burdette; H A Kenny; D Matei; J Pilrose; P Haluska; K P Nephew; D B Hales; M S Stack
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

2.  Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.

Authors:  Rachel A Davidowitz; Laura M Selfors; Marcin P Iwanicki; Kevin M Elias; Alison Karst; Huiying Piao; Tan A Ince; Michael G Drage; Judy Dering; Gottfried E Konecny; Ursula Matulonis; Gordon B Mills; Dennis J Slamon; Ronny Drapkin; Joan S Brugge
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

3.  Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Authors:  Pamela N Peters; Elizabeth M Schryver; Ernst Lengyel; Hilary Kenny
Journal:  J Vis Exp       Date:  2015-12-31       Impact factor: 1.355

4.  Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers.

Authors:  Kathryn M Burleson; Linda K Hansen; Amy P N Skubitz
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

Review 5.  Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis.

Authors:  Hilary A Kenny; Songuel Dogan; Marion Zillhardt; Anirban K Mitra; S Diane Yamada; Thomas Krausz; Ernst Lengyel
Journal:  Cancer Treat Res       Date:  2009

6.  LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.

Authors:  Davide Melisi; Satoshi Ishiyama; Guido M Sclabas; Jason B Fleming; Qianghua Xia; Giampaolo Tortora; James L Abbruzzese; Paul J Chiao
Journal:  Mol Cancer Ther       Date:  2008-04       Impact factor: 6.261

7.  Elevated expression of hyaluronic acid binding protein 1 (HABP1)/P32/C1QBP is a novel indicator for lymph node and peritoneal metastasis of epithelial ovarian cancer patients.

Authors:  Hongyang Yu; Qian Liu; Tao Xin; Lina Xing; Guanglu Dong; Qiuying Jiang; Yanju Lv; Xiaowei Song; Chong Teng; Dayong Huang; Yanju Li; Weixi Shen; Chong Teng; Yinghua Jin; Fubin Zhang
Journal:  Tumour Biol       Date:  2013-08-09

8.  Claudin 4 Is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation.

Authors:  Kristin L M Boylan; Benjamin Misemer; Melissa S De Rycke; John D Andersen; Katherine M Harrington; Steve E Kalloger; C Blake Gilks; Stefan E Pambuccian; Amy P N Skubitz
Journal:  Int J Mol Sci       Date:  2011-02-22       Impact factor: 5.923

Review 9.  Mechanisms of ovarian cancer metastasis: biochemical pathways.

Authors:  Kentaro Nakayama; Naomi Nakayama; Hiroshi Katagiri; Kohji Miyazaki
Journal:  Int J Mol Sci       Date:  2012-09-18       Impact factor: 6.208

10.  High adhesion of tumor cells to mesothelial monolayers derived from peritoneal wash of disseminated gastrointestinal cancers.

Authors:  Danilo Ranieri; Salvatore Raffa; Andrea Parente; Simone Rossi Del Monte; Vincenzo Ziparo; Maria Rosaria Torrisi
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.